Special Report: Medical cannabis company Creso Pharma has been winning customers around the world and has built on its bridgehead in Israel with a second customer order.
Creso Pharma (ASX:CPH) has picked up another customer order for its premium medicinal cannabis product, this time from Israel, after striking deals for Pakistan and South Africa. The Pakistan partnership is in the registration phase.
Israeli company Univo Pharmaceuticals has placed a $US625,000 ($894,653) order with Creso’s 100 per cent-owned subsidiary Mernova Medicinal for its premium, cured and hand-trimmed dried medicinal cannabis flower.
“Israel is widely recognised as one of the more progressive and active cannabis markets globally, and Univo’s acceptance and continued demand for our cannabis is a major testament to the quality of our product and the expertise of the Mernova team,” Creso chief executive and co-founder Dr Miri Halperin Wernli said.
Univo is a market leader in Israel’s growing medicinal cannabis market, and Creso said the order supports its entry into this market.
“Univo has an impressive distribution network, including significant connections to pharmacies and patients in Israel, so this truly is a tremendous growth opportunity for Creso,” Wernli said.